H

Hemostemix

12 employees

Hemostemix is a public clinical-stage biotechnology company.

Basic info

Industry

biotechnology research

Sectors

Clinical Trials
Biotechnology
Cardiovascular Disease
Peripheral Artery Disease
Therapeutics
Cell Therapy
Critical Limb Ischemia

Date founded

2006

Funding rounds raised

Total raised

$250K

from 1 investors over 1 rounds

H

Hemostemix raised $250K on January 19, 2023

Investors: Fondation de l'Hôpital Royal Victoria / Royal Victoria Hospital Foundation

FAQ